Summertime sees plenty of gatherings, and a spike in cases of some common sexually transmitted infections. That, combined with an overall upward trajectory of STIs, has physicians concerned and the Centers for Disease Control and Prevention ready with an action plan.

The CDC earlier this month released a report that found the antibiotic doxycycline successfully prevented syphilis, chlamydia and gonorrhea 70% of the time.

The agency moved to recommend that providers prescribe the antibiotic to men who have sex with men and transgender women following possible exposure to these STIs, called a post-exposure prophylactic (PEP) response.

“Doxy PEP represents the first new STI prevention tool in decades, at a time when innovation in the nation's fight against STIs is desperately needed,” Laura Bachmann and Jonathan Mermin, two CDC scientists and study authors, said in a June 4 news release regarding the guidelines.

Advertise with us

The total number of chlamydia, gonorrhea, syphilis and congenital cases were slightly lower in 2022 than the year prior, per the CDC, showing a 1% reduction in cases. But rates still demonstrate that millions of Americans are potentially at risk for long-term health effects, as well as a general upward trend of cases since 2018. There’s also been a spike in syphilis and congenital syphilis cases since 2021.

“Rates are high overall,” said Cassie Oehler, an infectious disease specialist at Allegheny Health Network’s Positive Health Clinic. “And there are a number of STDs that are not included in that [CDC] data,” such as trichomoniasis, herpes simplex virus and the bacteria mycoplasma, which can present like an STI.

Cory Haag, a registered nurse and clinic manager at Central Outreach Wellness Center’s North Shore location, said he’s seen syphilis and chlamydia rates increase in the clinic in recent months.

Allegheny County in particular has seen an uptick in gonorrhea cases since 2021, and Black residents are much more likely than their white counterparts to contract an STI: For gonorrhea, the rate is 11 times higher in this population than for whites, according to Allegheny County Health Department’s 2022 STI overview. Men are much more likely to be affected than cisgender women, cisgender referring to those whose gender identity aligns with the sex assigned at birth.

In its report, the CDC states that implementation of the new guidelines will require providers to remain focused and motivated on how best to equitably distribute resources, given these health inequities.

Advertise with us

The new recommendations state that providers should counsel all transgender women and men who have sex with men who have had an STI in the past year about Doxy PEP: both its benefits and its potential harms. The CDC suggests that providers address care holistically and practice a comprehensive approach, such as STI screening, testing for HIV, vaccination and risk reduction counseling.

Doxy PEP should be written as a self-administered prescription of 200 mg doses, with enough supply based on that person’s sexual activity. Providers should then check in within three to six months.

“Doxy PEP is something folks have been using in anticipation of these guidelines for a while now,” said Dr. Oehler. She said providers have been expecting updated guidelines for about a year.

“It’s nice to have something codified.”

Mr. Haag also confirmed that clinicians at Central Outreach have been treating the target population with Doxy PEP for a little over a year.

Advertise with us

“We’re really pushing the education and awareness around being able to have doxycycline on hand for patients at high risk,” said Mr. Haag. “These guidelines are a good confirmation to what physicians at Central Outreach have already known.”

CDC researchers, which included infectious disease specialists, public health officials and physicians with STI and HIV knowledge, as well as a separate bioethics working group, conducted the report by reviewing recent academic studies on the use of doxycycline to treat STIs.

The benefit of using doxycycline as a preventive strategy is two-fold. First, doxycycline is a common antibiotic providers are already comfortable with, said Dr. Oehler. Second, she said, there’s “clearly a need” for a treatment like this.

“There’s been a longstanding interest in strategies to prevent STDs since they’re so common,” said Dr. Oehler.

Researchers also looked at studies that examined the potential harms of doxycycline treatment. In that analysis, gastroenterological illness and antibiotic resistance were the most common adverse events reported. No serious events were reported in the three studies that were reviewed.

Advertise with us

Mr. Haag said there should be minimal to no side effects for most people, especially considering the treatment is typically a one-time dose. Patients should keep in mind sun sensitivity risks and apply sunscreen on days they take the medication. Those who are pregnant or breastfeeding should also consult their doctors before taking doxycycline.

According to the report, there is not currently enough evidence that Doxy PEP benefits cisgender women, cisgender straight men, transgender men or other nonbinary people assigned female at birth. The CDC recommends that providers use their clinical judgment when deciding whether to counsel members of these populations about Doxy PEP.

“We ask that everybody have a conversation with their clinician about Doxy PEP and the benefits it may have for them,” said Mr. Haag.

Stigma and shame may still hinder adequate Doxy PEP prescribing, as some are still reluctant to discuss sexual health and sexual histories, said Dr. Oehler.

It’s important to note that Doxy PEP does not address a range of other STI concerns, and while it’s a good intervention, Dr. Oehler said, it’s a limited intervention for a specific group of people.

Advertise with us

“This reduces the risk for common STIs, but it doesn’t obviate the need for a regular sexual health conversation,” she said. “It’s a tool, not the whole story.”

Hanna Webster: hwebster@post-gazette.com